Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: LTK007 who wrote (1049)	10/7/1999 4:45:00 PM
From: Saulamanca	Read Replies (1) \| Respond to of 2515

The patent infringement rumors are about method patents. The 1990 patent on C225 is a composition of matter patent. The rumors do not, repeat do not have anything to do with the product C225. The statement by Volpe Brown analyst David Lavigne about patent infringements, who wasn't even on this mornings conference call, were repeated on CNBC by David the brain dead Faber. Look what happened to HIFN today when another rumor was started about a supposed down grade by Robbie Stephens. This from briefing.com: 15:53 ET Hi/fn (HIFN) 74 -30 3/4: --Update-- Stock still halted. BancBoston Robertson Stephens issues a report clarifying analyst Arun Veerappan's comments on HIFN made this morning. Here are his comments, in their entirety: "In our view, Hi/fn is well positioned to exceed our September-quarter revenue and earnings-per-share estimates. In addition, we expect earnings estimates for the year ahead will remain unchanged. We expect that an inflection point in communications revenue could come when new customers (Lucent, Nortel) begin to ramp on VPN-enabling their platforms. We continue to view Hi/fn as a franchise company."

To: LTK007 who wrote (1049)	10/7/1999 4:58:00 PM
From: JOEBT1	Read Replies (1) \| Respond to of 2515

Max90-Waksal repeatedly said that IMCL does not infringe the Genentech patent-the purpose of the conference was to clarify the issue because there is no problem. He wasn't hedging in any way and made it very clear that there was no patent issue. After listening to a repeat of the conference I was a buyer. I understand that some of the institutions had to sell when the market cap fell below 750M and of course the day traders jumped in exaggerating the down side. So the way I see it is that this is the same IMCL that reached the mid 30s and it's very likely to move up when the market noise diminishes and the above is understood.